References
1. Australian Institute of Health and Welfare. Cancer data in Australia. Canberra: AIHW, 2022. Available from: https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia.
2. Australian Institute of Health and Welfare. Head and neck cancers in Australia. Cat. number CAN 80, Cat. number CAN 80: AIHW, 2014. Available from: https://www.aihw.gov.au/getmedia/bdccebf2-dbe6-44e2-9104-8461d7e7c165/16933.pdf.aspx?inline=true.
3. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncology, 2009; 45(4-5):309-16. Available from: https://www.ncbi.nlm.nih.gov/pubmed/18804401
4. International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Volume 83. Lyon: International Agency for Research on Cancer, 2004. Available from: https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Tobacco-Smoke-And-Involuntary-Smoking-2004.
5. Macfarlane TV, Macfarlane GJ, Oliver RJ, Benhamou S, Bouchardy C, et al. The aetiology of upper aerodigestive tract cancers among young adults in Europe: the ARCAGE study. Cancer Causes and Control, 2010; 21(12):2213-21. Available from: https://www.ncbi.nlm.nih.gov/pubmed/20835759
6. US Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. Atlanta, Georgia: US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004. Available from: https://www.cdc.gov/tobacco/data_statistics/sgr/2004/complete_report/index.htm.
7. Ansary-Moghaddam A, Huxley RR, Lam TH, and Woodward M. The risk of upper aero digestive tract cancer associated with smoking, with and without concurrent alcohol consumption. Mount Sinai Journal of Medicine, 2009; 76(4):392-403. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19642154
8. Weber MF, Sarich PEA, Vaneckova P, Wade S, Egger S, et al. Cancer incidence and cancer death in relation to tobacco smoking in a population-based Australian cohort study. International Journal of Cancer, 2021. Available from: https://pubmed.ncbi.nlm.nih.gov/34015143/
9. Enzinger PC and Mayer RJ. Esophageal cancer. New England Journal of Medicine, 2003; 349(23):2241-52. Available from: https://www.ncbi.nlm.nih.gov/pubmed/14657432
10. Castro C, Peleteiro B, and Lunet N. Modifiable factors and esophageal cancer: a systematic review of published meta-analyses. Journal of Gastroenterology, 2018; 53(1):37-51. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28821981
11. Wang QL, Xie SH, Li WT, and Lagergren J. Smoking cessation and risk of esophageal cancer by histological type: systematic review and meta-analysis. Journal of the National Cancer Institute, 2017; 109(12). Available from: https://www.ncbi.nlm.nih.gov/pubmed/29933436
12. Cook MB, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. Journal of the National Cancer Institute, 2010; 102(17):1344-53. Available from: https://www.ncbi.nlm.nih.gov/pubmed/20716718
13. Tramacere I, La Vecchia C, and Negri E. Tobacco smoking and esophageal and gastric cardia adenocarcinoma: a meta-analysis. Epidemiology, 2011; 22(3):344-9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21330928
14. Pandeya N, Williams GM, Sadhegi S, Green AC, Webb PM, et al. Associations of duration, intensity, and quantity of smoking with adenocarcinoma and squamous cell carcinoma of the esophagus. American Journal of Epidemiology, 2008; 168(1):105-14. Available from: https://www.ncbi.nlm.nih.gov/pubmed/18483122
15. Asombang AW, Chishinga N, Nkhoma A, Chipaila J, Nsokolo B, et al. Systematic review and meta-analysis of esophageal cancer in Africa: Epidemiology, risk factors, management and outcomes. World Journal of Gastroenterology, 2019; 25(31):4512-33. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31496629
16. Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, et al. Tobacco smoking and cancer: a meta-analysis. International Journal of Cancer, 2008; 122(1):155-64. Available from: https://www.ncbi.nlm.nih.gov/pubmed/17893872
17. Asthana S, Labani S, Kailash U, Sinha DN, and Mehrotra R. Association of smokeless tobacco use and oral cancer: a systematic global review and meta-analysis. Nicotine and Tobacco Research, 2019; 21(9):1162-71. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29790998
18. Sinha DN, Abdulkader RS, and Gupta PC. Smokeless tobacco-associated cancers: A systematic review and meta-analysis of Indian studies. International Journal of Cancer, 2016; 138(6):1368-79. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26443187
19. Long M, Fu Z, Li P, and Nie Z. Cigarette smoking and the risk of nasopharyngeal carcinoma: a meta-analysis of epidemiological studies. BMJ Open, 2017; 7(10):e016582. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28982817
20. US Department of Health and Human Services. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease. A report of the US Surgeon General, Atlanta, Georgia: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2010. Available from: https://www.ncbi.nlm.nih.gov/books/NBK53017/.
21. Khariwala SS, Ma B, Ruszczak C, Carmella SG, Lindgren B, et al. High level of tobacco carcinogen-derived DNA damage in oral cells is an independent predictor of oral/head and neck cancer risk in smokers. Cancer Prevention Research, 2017; 10(9):507-13. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28679497
22. Sabitha K, Reddy MV, and Jamil K. Smoking related risk involved in individuals carrying genetic variants of CYP1A1 gene in head and neck cancer. Cancer Epidemiology, 2010; 34(5):587-92. Available from: https://www.ncbi.nlm.nih.gov/pubmed/20887941
23. Jaloszynski P, Jaruga P, Olinski R, Biczysko W, Szyfter W, et al. Oxidative DNA base modifications and polycyclic aromatic hydrocarbon DNA adducts in squamous cell carcinoma of larynx. Free Radical Research, 2003; 37(3):231-40. Available from: https://www.ncbi.nlm.nih.gov/pubmed/12688418
24. South AP, den Breems NY, Richa T, Nwagu U, Zhan T, et al. Mutation signature analysis identifies increased mutation caused by tobacco smoke associated DNA adducts in larynx squamous cell carcinoma compared with oral cavity and oropharynx. Scientific Reports, 2019; 9(1):19256. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31848367
25. Khan AA, Patel K, Patil S, Babu N, Mangalaparthi KK, et al. Multi-omics analysis to characterize cigarette smoke induced molecular alterations in esophageal cells. Frontiers in Oncology, 2020; 10:1666. Available from: https://www.ncbi.nlm.nih.gov/pubmed/33251127
26. Zhou R, Li Y, Wang N, Niu C, Huang X, et al. PARP1 rs1136410 C/C genotype associated with an increased risk of esophageal cancer in smokers. Molecular Biology Reports, 2021; 48(2):1485-91. Available from: https://www.ncbi.nlm.nih.gov/pubmed/33528729
27. Al-Zyoud W, Hajjo R, Abu-Siniyeh A, and Hajjaj S. Salivary microbiome and cigarette smoking: a first of its kind investigation in Jordan. International Journal of Environmental Research and Public Health, 2019; 17(1). Available from: https://www.ncbi.nlm.nih.gov/pubmed/31905907
28. Zhang ZJ, Hao K, Shi R, Zhao G, Jiang GX, et al. Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: a HuGE review and meta-analysis. American Journal of Epidemiology, 2011; 173(8):847-57. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21436184
29. Lubin JH, Purdue M, Kelsey K, Zhang ZF, Winn D, et al. Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case-control studies. American Journal of Epidemiology, 2009; 170(8):937-47. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19745021
30. Di Credico G, Edefonti V, Polesel J, Pauli F, Torelli N, et al. Joint effects of intensity and duration of cigarette smoking on the risk of head and neck cancer: A bivariate spline model approach. Oral Oncology, 2019; 94:47-57. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31178212
31. Tomar SL. Duration of cigarette smoking is a stronger risk factor than number of cigarettes smoked per day for head and neck cancer, and quitting dramatically lowers the risk. Journal of Evidence-Based Dental Practice, 2020; 20(1):101419. Available from: https://www.ncbi.nlm.nih.gov/pubmed/32381417
32. Hashibe M, Brennan P, Chuang SC, Boccia S, Castellsague X, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiology, Biomarkers and Prevention, 2009; 18(2):541–50. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051410/pdf/nihms270552.pdf
33. Kobayashi K, Hisamatsu K, Suzui N, Hara A, Tomita H, et al. A review of HPV-related head and neck cancer. Journal of Clinical Medicine, 2018; 7(9). Available from: https://www.ncbi.nlm.nih.gov/pubmed/30150513
34. Chaitanya NC, Allam NS, Gandhi Babu DB, Waghray S, Badam RK, et al. Systematic meta-analysis on association of human papilloma virus and oral cancer. Journal of Cancer Research and Therapeutics, 2016; 12(2):969-74. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27461683
35. Mirghani H, Leroy C, Chekourry Y, Casiraghi O, Auperin A, et al. Smoking impact on HPV driven head and neck cancer's oncological outcomes? Oral Oncology, 2018; 82:131-7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29909887
36. Liu HY, Daniels CP, Trada Y, Bernard A, You KH, et al. The importance of smoking status at diagnosis in human papillomavirus-associated oropharyngeal cancer. Head and Neck, 2021; 43(5):1440-50. Available from: https://www.ncbi.nlm.nih.gov/pubmed/33427358
37. Chen SY, Last A, Ettyreddy A, Kallogjeri D, Wahle B, et al. 20 pack-year smoking history as strongest smoking metric predictive of HPV-positive oropharyngeal cancer outcomes. American Journal of Otolaryngology, 2021; 42(3):102915. Available from: https://www.ncbi.nlm.nih.gov/pubmed/33482566
38. Madathil S, Rousseau MC, Joseph L, Coutlee F, Schlecht NF, et al. Latency of tobacco smoking for head and neck cancer among HPV-positive and HPV-negative individuals. International Journal of Cancer, 2020; 147(1):56-64. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31584196
39. US Department of Health and Human Services. Smoking cessation. A report of the Surgeon General. Atlanta, GA U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Centre for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health 2020. Available from: https://www.cdc.gov/tobacco/data_statistics/sgr/2020-smoking-cessation/.
40. International Agency for Research on Cancer. Reversal of risk after quitting smoking. IARC handbooks of cancer prevention, tobacco control, 11 Vol. 11.Lyon, France: IARC, 2007. Available from: https://publications.iarc.fr/Book-And-Report-Series/Iarc-Handbooks-Of-Cancer-Prevention/Tobacco-Control-Reversal-Of-Risk-After-Quitting-Smoking-2007.
41. Marron M, Boffetta P, Zhang ZF, Zaridze D, Wunsch-Filho V, et al. Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. International Journal of Epidemiology, 2010; 39(1):182-96. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19805488
42. Smith J, Nastasi D, Tso R, Vangaveti V, Renison B, et al. The effects of continued smoking in head and neck cancer patients treated with radiotherapy: A systematic review and meta-analysis. Radiotherapy and Oncology, 2019; 135:51-7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31015170
43. Kuang JJ, Jiang ZM, Chen YX, Ye WP, Yang Q, et al. Smoking exposure and survival of patients with esophagus cancer: a systematic review and meta-analysis. Gastroenterology Research and Practice, 2016; 2016:7682387. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27073394
44. Fortin A, Wang CS, and Vigneault E. Influence of smoking and alcohol drinking behaviors on treatment outcomes of patients with squamous cell carcinomas of the head and neck. International Journal of Radiation Oncology, Biology, Physics, 2009; 74(4):1062-9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19036528
45. Chen AM, Chen LM, Vaughan A, Farwell DG, Luu Q, et al. Head and neck cancer among lifelong never-smokers and ever-smokers: matched-pair analysis of outcomes after radiation therapy. American Journal of Clinical Oncology, 2011; 34(3):270-5. Available from: https://www.ncbi.nlm.nih.gov/pubmed/20622648
46. Duffy S, Ronis D, McLean S, Fowler K, Gruber S, et al. Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma Journal of Clinical Oncology, 2009; 27(12):1969-75. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669762/
47. Mayne ST, Cartmel B, Kirsh V, and Goodwin WJ, Jr. Alcohol and tobacco use prediagnosis and postdiagnosis, and survival in a cohort of patients with early stage cancers of the oral cavity, pharynx, and larynx. Cancer Epidemiology, Biomarkers and Prevention, 2009; 18(12):3368-74. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19959684
48. Chen AM, Chen LM, Vaughan A, Sreeraman R, Farwell DG, et al. Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome. International Journal of Radiation Oncology, Biology, Physics, 2011; 79(2):414-9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/20399030
49. Hilgert E, Bergmann C, Fichtner A, Gires O, and Issing W. Tobacco abuse relates to significantly reduced survival of patients with oropharyngeal carcinomas. European Journal of Cancer Prevention, 2009; 18(2):120–6. Available from: http://journals.lww.com/eurjcancerprev/pages/articleviewer.aspx?year=2009&issue=04000&article=00005&type=abstract
50. Vincent A, Herman J, Schulick R, Hruban RH, and Goggins M. Pancreatic cancer. Lancet, 2011; 378(9791):607-20. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21620466
51. Cancer Australia. Pancreatic cancer in Australia statistics. Sydney, Australia: Cancer Australia, 2022. Available from: https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/contents/about.
52. Lynch SM, Vrieling A, Lubin JH, Kraft P, Mendelsohn JB, et al. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. American Journal of Epidemiology, 2009; 170(4):403-13. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19561064
53. Maisonneuve P and Lowenfels AB. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. International Journal of Epidemiology, 2015; 44(1):186-98. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25502106
54. Lugo A, Peveri G, Bosetti C, Bagnardi V, Crippa A, et al. Strong excess risk of pancreatic cancer for low frequency and duration of cigarette smoking: A comprehensive review and meta-analysis. European Journal of Cancer, 2018; 104:117-26. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30347287
55. Wittel UA, Momi N, Seifert G, Wiech T, Hopt UT, et al. The pathobiological impact of cigarette smoke on pancreatic cancer development (review). International Journal of Oncology, 2012; 41(1):5-14. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22446714
56. Adair T, Hoy D, Dettrick Z, and Lopez AD. Tobacco consumption and pancreatic cancer mortality: what can we conclude from historical data in Australia? European Journal of Public Health, 2012; 22(2):243-7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21616993
57. Korc M, Jeon CY, Edderkaoui M, Pandol SJ, Petrov MS, et al. Tobacco and alcohol as risk factors for pancreatic cancer. Best Practice and Research. Clinical Gastroenterology, 2017; 31(5):529-36. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29195672
58. Ben QW, Liu J, Sun YW, Wang LF, Zou DW, et al. Cigarette smoking and mortality in patients with pancreatic cancer: A systematic review and meta-analysis. Pancreas, 2019; 48(8):985-95. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31425484
59. Rawla P and Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Przegląd Gastroenterologiczny, 2019; 14(1):26-38. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30944675
60. Cancer Australia. Stomach cancer in Australia statistics. Sydney, Australia: Cancer Australia, 2022. Available from: https://www.canceraustralia.gov.au/cancer-types/stomach-cancer/statistics.
61. Hu B, El Hajj N, Sittler S, Lammert N, Barnes R, et al. Gastric cancer: Classification, histology and application of molecular pathology. Journal of Gastrointestinal Oncology, 2012; 3(3):251-61. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22943016
62. La Torre G, Chiaradia G, Gianfagna F, De Lauretis A, Boccia S, et al. Smoking status and gastric cancer risk: an updated meta-analysis of case-control studies published in the past ten years. Tumori, 2009; 95(1):13-22. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19366050
63. Poorolajal J, Moradi L, Mohammadi Y, Cheraghi Z, and Gohari-Ensaf F. Risk factors for stomach cancer: a systematic review and meta-analysis. Epidemiology and Health, 2020; 42:e2020004. Available from: https://www.ncbi.nlm.nih.gov/pubmed/32023777
64. Whetton S, Tait RJ, Scollo M, Banks E, Chapman J, et al. Identifying the social costs of tobacco use to Australia in 2015/16. National Drug Research Institute, Curtin University, 2019. Available from: https://ndri.curtin.edu.au/NDRI/media/documents/publications/T273.pdf.
65. Wang W, Chin-Sheng H, Kuo LJ, Wei PL, Lien YC, et al. NNK enhances cell migration through alpha7-nicotinic acetylcholine receptor accompanied by increased of fibronectin expression in gastric cancer. Annals of Surgical Oncology, 2012; 19 Suppl 3:S580-8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21969082
66. Shin VY, Jin HC, Ng EK, Cho CH, Leung WK, et al. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone promoted gastric cancer growth through prostaglandin E receptor (EP2 and EP4) in vivo and in vitro. Cancer Science, 2011; 102(5):926-33. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21261791
67. US Department of Health and Human Services. The health benefits of smoking cessation. A report of the Surgeon General. Atlanta, GA: Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1990. Available from: https://stacks.cdc.gov/view/cdc/84624.
68. Shikata K, Doi Y, Yonemoto K, Arima H, Ninomiya T, et al. Population-based prospective study of the combined influence of cigarette smoking and Helicobacter pylori infection on gastric cancer incidence: the Hisayama Study. American Journal of Epidemiology, 2008; 168(12):1409-15. Available from: https://www.ncbi.nlm.nih.gov/pubmed/18945691
69. National Cancer Institute. Helicobacter pylori and Cancer USA 2013. Available from: https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/h-pylori-fact-sheet.
70. Li WY, Han Y, Xu HM, Wang ZN, Xu YY, et al. Smoking status and subsequent gastric cancer risk in men compared with women: a meta-analysis of prospective observational studies. BMC Cancer, 2019; 19(1):377. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31014273
71. Cancer Australia. Kidney cancer in Australia statistics. Sydney, Australia: Cancer Australia, 2022. Available from: https://www.canceraustralia.gov.au/cancer-types/kidney-cancer/statistics.
72. Cancer Australia. Bladder cancer in Australia statistics. Sydney, Australia: Cancer Australia, 2022. Available from: https://www.canceraustralia.gov.au/cancer-types/bladder-cancer/statistics.
73. Liu X, Peveri G, Bosetti C, Bagnardi V, Specchia C, et al. Dose-response relationships between cigarette smoking and kidney cancer: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology, 2019; 142:86-93. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31387065
74. van Osch FH, Jochems SH, van Schooten FJ, Bryan RT, and Zeegers MP. Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies. International Journal of Epidemiology, 2016; 45(3):857-70. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27097748
75. Pandeya N, Wilson LF, Bain CJ, Martin KL, Webb PM, et al. Cancers in Australia in 2010 attributable to tobacco smoke. Australian and New Zealand Journal of Public Health, 2015; 39(5):464-70. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26437733
76. Baris D, Karagas MR, Verrill C, Johnson A, Andrew AS, et al. A case-control study of smoking and bladder cancer risk: emergent patterns over time. Journal of the National Cancer Institute, 2009; 101(22):1553-61. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19917915
77. Alberg AJ and Hebert JR. Cigarette smoking and bladder cancer: a new twist in an old saga? Journal of the National Cancer Institute, 2009; 101(22):1525-6. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19917914
78. Hunt JD, van der Hel OL, McMillan GP, Boffetta P, and Brennan P. Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. International Journal of Cancer, 2005; 114(1):101-8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/15523697
79. van Osch FHM, Vlaanderen J, Jochems SHJ, Bosetti C, Polesel J, et al. Modeling the complex exposure history of smoking in predicting bladder cancer: A pooled analysis of 15 case-control studies. Epidemiology, 2019; 30(3):458-65. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30601243
80. Janisch F, Shariat SF, Schernhammer E, Rink M, and Fajkovic H. The interaction of gender and smoking on bladder cancer risks. Current Opinion in Urology, 2019; 29(3):249-55. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30888973
81. Aveyard P, Adab P, Cheng K, Wallace D, Hey K, et al. Does smoking status influence the prognosis of bladder cancer? A systematic review. BJU International, 2002; 90(3):228-39. Available from: http://www.phc.ox.ac.uk/publications/311349
82. Rink M, Furberg H, Zabor EC, Xylinas E, Babjuk M, et al. Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer. European Urology, 2013; 63(4):724-32. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22925575
83. Hara T, Fujimoto H, Kondo T, Shinohara N, Obara W, et al. Active heavy cigarette smoking is associated with poor survival in Japanese patients with advanced renal cell carcinoma: sub-analysis of the multi-institutional national database of the Japanese Urological Association. Japanese Journal of Clinical Oncology, 2017; 47(12):1162-9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29121328
84. Gild P, Vetterlein MW, Seiler R, Necchi A, Hendricksen K, et al. The association of cigarette smoking and pathological response to neoadjuvant platinum-based chemotherapy in patients undergoing treatment for urinary bladder cancer - A prospective European multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working group. Surgical Oncology, 2020; 34:312-7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/32891350
85. He T, Hu J, Qiu D, Deng H, Hu J, et al. Smoking status and pathological response to neoadjuvant chemotherapy among patients with bladder cancer: a pooled analysis. Translational Andrology and Urology, 2021; 10(1):374-83. Available from: https://www.ncbi.nlm.nih.gov/pubmed/33532325
86. Xu Y, Qi Y, Zhang J, Lu Y, Song J, et al. The impact of smoking on survival in renal cell carcinoma: a systematic review and meta-analysis. Tumour Biology, 2014; 35(7):6633-40. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24699995
87. Tellini R, Mari A, Muto G, Cacciamani GE, Ferro M, et al. Impact of smoking habit on perioperative morbidity in patients treated with radical cystectomy for urothelial bladder cancer: A systematic review and meta-analysis. European Urology Oncology, 2020. Available from: https://www.ncbi.nlm.nih.gov/pubmed/33160975
88. Canfell K, Sitas F, and Beral V. Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality. Medical Journal of Australia, 2006; 185(9):482-6. Available from: https://www.ncbi.nlm.nih.gov/pubmed/17137451
89. Cancer Australia. Cervical cancer in Australia statistics. Sydney, Australia: Cancer Australia, 2022. Available from: https://www.canceraustralia.gov.au/cancer-types/cervical-cancer/statistics.
90. Collins S, Rollason TP, Young LS, and Woodman CB. Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: a longitudinal study. European Journal of Cancer, 2010; 46(2):405-11. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19819687
91. Kapeu A, Luostarinen T, Jellum E, Dillner J, Hakama M, et al. Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks. American Journal of Epidemiology, 2009; 169(4):480–8. Available from: http://aje.oxfordjournals.org/cgi/content/full/169/4/480
92. Sugawara Y, Tsuji I, Mizoue T, Inoue M, Sawada N, et al. Cigarette smoking and cervical cancer risk: an evaluation based on a systematic review and meta-analysis among Japanese women. Japanese Journal of Clinical Oncology, 2019; 49(1):77-86. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30407555
93. Su B, Qin W, Xue F, Wei X, Guan Q, et al. The relation of passive smoking with cervical cancer: A systematic review and meta-analysis. Medicine, 2018; 97(46):e13061. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30431576
94. Zeng XT, Xiong PA, Wang F, Li CY, Yao J, et al. Passive smoking and cervical cancer risk: a meta-analysis based on 3,230 cases and 2,982 controls. Asian Pacific Journal of Cancer Prevention, 2012; 13(6):2687-93. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22938442
95. Sherman JF, Mount SL, Evans MF, Skelly J, Simmons-Arnold L, et al. Smoking increases the risk of high-grade vaginal intraepithelial neoplasia in women with oncogenic human papillomavirus. Gynecologic Oncology, 2008; 110(3):396-401. Available from: https://www.ncbi.nlm.nih.gov/pubmed/18586314
96. Khan AM, Freeman-Wang T, Pisal N, and Singer A. Smoking and multicentric vulval intraepithelial neoplasia. Journal of Obstetrics and Gynaecology, 2009; 29(2):123-5. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19274545
97. Gadducci A, Barsotti C, Cosio S, Domenici L, and Riccardo Genazzani A. Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature. Gynecological Endocrinology, 2011; 27(8):597-604. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21438669
98. Xi LF, Koutsky LA, Castle PE, Edelstein ZR, Meyers C, et al. Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load. Cancer Epidemiology, Biomarkers and Prevention, 2009; 18(12):3490-6. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19959700
99. Coker A, Desimone C, Eggleston K, Hopenhayn C, Nee J, et al. Smoking and survival among Kentucky women diagnosed with invasive cervical cancer: 1995–2005 Gynecologic Oncology, 2008; 112(2):365-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19036421
100. Mayadev J, Lim J, Durbin-Johnson B, Valicenti R, and Alvarez E. Smoking decreases survival in locally advanced cervical cancer treated with radiation. American Journal of Clinical Oncology, 2018; 41(3):295-301. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26808259
101. Australian Institute of Health and Welfare. Cancer survival and prevalence in Australia: cancers diagnosed from 1982 to 2004. Cancer series no. 42. AIHW cat. no CAN 38, Canberra: AIHW, 2008. Available from: http://www.aihw.gov.au/publication-detail/?id=6442468141&libID=6442468139.
102. Australian Institute of Health and Welfare. Cancer. Canberra: AIHW, 2011. Available from: http://www.aihw.gov.au/cancer/.
103. Colamesta V, D'Aguanno S, Breccia M, Bruffa S, Cartoni C, et al. Do the smoking intensity and duration, the years since quitting, the methodological quality and the year of publication of the studies affect the results of the meta-analysis on cigarette smoking and Acute Myeloid Leukemia (AML) in adults? Critical Reviews in Oncology/Hematology, 2016; 99:376-88. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26830008
104. Shi H, Shao X, and Hong Y. Association between cigarette smoking and the susceptibility of acute myeloid leukemia: a systematic review and meta-analysis. European Review for Medical and Pharmacological Sciences, 2019; 23(22):10049-57. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31799675
105. Metayer C, Petridou E, Arangure JM, Roman E, Schuz J, et al. Parental tobacco smoking and acute myeloid leukemia: The Childhood Leukemia International Consortium. American Journal of Epidemiology, 2016; 184(4):261-73. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27492895
106. International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans. Chemicals, industrial processes, and industries associated with cancer in humans. IARC monographs Vol 1-29, Suppl 4 Lyon, France: International Agency for Research on Cancer, 1982. Available from: https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-Supplements/Chemicals-Industrial-Processes-And-Industries-Associated-With-Cancer-In-Humans-IARC-Monographs-Volumes-1-To-29--1982.
107. Korte JE, Hertz-Picciotto I, Schulz MR, Ball LM, and Duell EJ. The contribution of benzene to smoking-induced leukemia. Environmental Health Perspectives, 2000; 108(4):333-9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/10753092
108. Fiebelkorn S and Meredith C. Estimation of the leukemia risk in human populations exposed to benzene from tobacco smoke using epidemiological data. Risk Analysis, 2018; 38(7):1490-501. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29266361
109. Varadarajan R, Licht AS, Hyland AJ, Ford LA, Sait SN, et al. Smoking adversely affects survival in acute myeloid leukemia patients. International Journal of Cancer, 2012; 130(6):1451-8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21520043
110. Ehlers SL, Gastineau DA, Patten CA, Decker PA, Rausch SM, et al. The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia. Bone Marrow Transplantation, 2011; 46(2):285-90. Available from: https://www.ncbi.nlm.nih.gov/pubmed/20479707
111. Australian Institute of Health and Welfare. Cancer in Australia 2019. Cancer series no.119, Cat. no. CAN 123 Canberra: AIHW, 2019. Available from: https://www.aihw.gov.au/getmedia/8c9fcf52-0055-41a0-96d9-f81b0feb98cf/aihw-can-123.pdf.aspx?inline=true.
112. Cancer Australia. Liver cancer in Australia statistics. Sydney, Australia: Cancer Australia, 2020. Available from: https://liver-cancer.canceraustralia.gov.au/statistics.
113. US Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014. Available from: https://www.ncbi.nlm.nih.gov/books/NBK179276/pdf/Bookshelf_NBK179276.pdf.
114. Lee YC, Cohet C, Yang YC, Stayner L, Hashibe M, et al. Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer. International Journal of Epidemiology, 2009; 38(6):1497-511. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19720726
115. Abdel-Rahman O, Helbling D, Schob O, Eltobgy M, Mohamed H, et al. Cigarette smoking as a risk factor for the development of and mortality from hepatocellular carcinoma: An updated systematic review of 81 epidemiological studies. Journal of Evidence-Based Medicine, 2017; 10(4):245-54. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28891275
116. Pelucchi C, Gallus S, Garavello W, Bosetti C, and La Vecchia C. Cancer risk associated with alcohol and tobacco use: focus on upper aero-digestive tract and liver. Alcohol Research and Health, 2006; 29(3):193-8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/17373408
117. Yu MW, Hsu FC, Sheen IS, Chu CM, Lin DY, et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. American Journal of Epidemiology, 1997; 145(11):1039-47. Available from: https://www.ncbi.nlm.nih.gov/pubmed/9169913
118. Hezode C, Lonjon I, Roudot-Thoraval F, Mavier JP, Pawlotsky JM, et al. Impact of smoking on histological liver lesions in chronic hepatitis C. Gut, 2003; 52(1):126-9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/12477773
119. Chuang SC, Lee YC, Hashibe M, Dai M, Zheng T, et al. Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer Epidemiology, Biomarkers and Prevention, 2010; 19(5):1261-8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/20447919
120. Pang Q, Qu K, Zhang J, Xu X, Liu S, et al. Cigarette smoking increases the risk of mortality from liver cancer: A clinical-based cohort and meta-analysis. Journal of Gastroenterology and Hepatology, 2015; 30(10):1450-60. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25967392
121. Cancer Australia. Bowel cancer in Australia statistics. Sydney, Australia: Cancer Australia, 2022. Available from: https://www.canceraustralia.gov.au/cancer-types/bowel-cancer/statistics.
122. Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, et al. Smoking and colorectal cancer: a meta-analysis. JAMA, 2008; 300(23):2765-78. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19088354
123. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, et al. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. International Journal of Cancer, 2009; 125(1):171-80. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19350627
124. Liang PS, Chen TY, and Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. International Journal of Cancer, 2009; 124(10):2406-15. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19142968
125. Tsoi KK, Pau CY, Wu WK, Chan FK, Griffiths S, et al. Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clinical Gastroenterology and Hepatology, 2009; 7(6):682-8 e1-5. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19245853
126. Hannan LM, Jacobs EJ, and Thun MJ. The association between cigarette smoking and risk of colorectal cancer in a large prospective cohort from the United States. Cancer Epidemiology, Biomarkers and Prevention, 2009; 18(12):3362-7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19959683
127. Dimou N, Yarmolinsky J, Bouras E, Tsilidis KK, Martin RM, et al. Causal effects of lifetime smoking on breast and colorectal cancer risk: Mendelian randomization study. Cancer Epidemiology, Biomarkers and Prevention, 2021; 30(5):953-64. Available from: https://www.ncbi.nlm.nih.gov/pubmed/33653810
128. Acott A, Theus S, Marchant-Miros K, and Mancino A. Association of tobacco and alcohol use with earlier development of colorectal cancer: should we modify screening guidelines? American Journal of Surgery, 2008; 196(6):915–9. Available from: https://pubmed.ncbi.nlm.nih.gov/19095109/
129. Limsui D, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. Journal of the National Cancer Institute, 2010; 102(14):1012-22. Available from: https://www.ncbi.nlm.nih.gov/pubmed/20587792
130. Raimondi S, Botteri E, Iodice S, Lowenfels AB, and Maisonneuve P. Gene-smoking interaction on colorectal adenoma and cancer risk: review and meta-analysis. Mutation Research, 2009; 670(1-2):6-14. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19589345
131. Makino A, Tsuruta M, Okabayashi K, Ishida T, Shigeta K, et al. The impact of smoking on pulmonary metastasis in colorectal cancer. OncoTargets and Therapy, 2020; 13:9623-9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/33061444
132. Boland CR and Goel A. Clearing the air on smoking and colorectal cancer. Journal of the National Cancer Institute, 2010; 102(14):996-7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/20587791
133. Chen X, Jansen L, Guo F, Hoffmeister M, Chang-Claude J, et al. Smoking, genetic predisposition, and colorectal cancer risk. Clinical and Translational Gastroenterology, 2021; 12(3):e00317. Available from: https://www.ncbi.nlm.nih.gov/pubmed/33646204
134. Ordonez-Mena JM, Walter V, Schottker B, Jenab M, O'Doherty MG, et al. Impact of pre-diagnostic smoking and smoking cessation on colorectal cancer prognosis: a meta-analysis of individual patient data from cohorts within the CHANCES consortium. Annals of Oncology, 2018; 29:472-83. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29244072
135. Cebohin M, Samardzic S, Marjanovic K, Tot Vesic M, Kralik K, et al. Adenoma Characteristics and the Influence of Alcohol and Cigarette Consumption on the Development of Advanced Colorectal Adenomas. International Journal of Environmental Research and Public Health, 2020; 17(22). Available from: https://www.ncbi.nlm.nih.gov/pubmed/33182591
136. Ramamoorthy S, Luo L, Luo E, and Carethers JM. Tobacco smoking and risk of recurrence for squamous cell cancer of the anus. Cancer Detection and Prevention, 2008; 32(2):116-20. Available from: https://www.ncbi.nlm.nih.gov/pubmed/18639388
137. Cancer Australia. Breast cancer in Australia statistics. Sydney, Australia: Cancer Australia, 2022. Available from: https://www.canceraustralia.gov.au/cancer-types/breast-cancer/statistics.
138. Centers for Disease Control and Prevention. Breast Cancer. What are the risk factors? USA: US Department of Health & Human Services, 2018. Available from: https://www.cdc.gov/cancer/breast/basic_info/risk_factors.htm.
139. Xu Z, Xu H, and Lu Y. Genetic liability to smoking and breast cancer risk. Clinical Epidemiology, 2020; 12:1145-8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/33116908
140. Johnson KC, Miller AB, Collishaw NE, Palmer JR, Hammond SK, et al. Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009). Tobacco Control, 2011; 20(1):e2. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21148114
141. Sollie M and Bille C. Smoking and mortality in women diagnosed with breast cancer-a systematic review with meta-analysis based on 400,944 breast cancer cases. Gland Surgery, 2017; 6(4):385-93. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28861380
142. Karunanayake CP, Singh GV, Spinelli JJ, McLaughlin JR, Dosman JA, et al. Occupational exposures and Hodgkin Lymphoma: Canadian case-control study. Journal of Occupational and Environmental Medicine, 2009; 51(12):1447-54. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19952792
143. Huncharek M, Haddock KS, Reid R, and Kupelnick B. Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies. American Journal of Public Health, 2010; 100(4):693-701. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19608952
144. Watters JL, Park Y, Hollenbeck A, Schatzkin A, and Albanes D. Cigarette smoking and prostate cancer in a prospective US cohort study. Cancer Epidemiology, Biomarkers and Prevention, 2009; 18(9):2427-35. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19706848
145. Zu K and Giovannucci E. Smoking and aggressive prostate cancer: a review of the epidemiologic evidence. Cancer Causes and Control, 2009; 20(10):1799-810. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19562492
146. Foerster B, Pozo C, Abufaraj M, Mari A, Kimura S, et al. Association of smoking status with recurrence, metastasis, and mortality among patients with localized prostate cancer undergoing prostatectomy or radiotherapy: A systematic review and meta-analysis. JAMA Oncology, 2018; 4(7):953-61. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29800115
147. Sato N, Shiota M, Shiga KI, Kashiwagi E, Takeuchi A, et al. Effect of smoking on oncological outcome among prostate cancer patients after radical prostatectomy with neoadjuvant hormonal therapy. Cancer Investigation, 2020; 38(10):559-64. Available from: https://www.ncbi.nlm.nih.gov/pubmed/33016145
148. International Agency for Research on Cancer, Personal habits and indoor combustions. IARC Monographs Vol. Volume 100 E A review of human carcinogens.Lyon, France: IARC; 2012. Available from: https://www.ncbi.nlm.nih.gov/books/NBK304391/.
149. Hermans K, van den Brandt PA, Loef C, Jansen RLH, and Schouten LJ. Alcohol consumption, cigarette smoking and cancer of unknown primary risk: Results from the Netherlands Cohort Study. International Journal of Cancer, 2021; 148(7):1586-97. Available from: https://www.ncbi.nlm.nih.gov/pubmed/33022785